Insmed vs Legend Biotech
INSM and LEGN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INSM and LEGN compare
Insmed grew revenue faster over the last twelve months (240% versus 59.5% for Legend Biotech).
Insmed scores higher on the StockData Score (8 against 3 for Legend Biotech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INSM | LEGN |
|---|---|---|
| Size and price | ||
| Market cap | $26.7B | – |
| Share price | $121.86 | $16.11 |
| Change, 1 year | −36.9% | −46.8% |
| Change, 5 years | 321% | −70.2% |
| Beta (5Y) | 0.84 | 0.80 |
| Employees | 1,664 | 2,900 |
| StockData Score | ||
| Total score | 8 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 2 (better) | 0 |
| Health score | 3 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 17.6× | – |
| P/B | 36.8× | – |
| FCF yield | −2.3% | – |
| Fair value | $61.10 | – |
| Margin of safety | −99.5% | – |
| Growth | ||
| Revenue growth (TTM) | 240% (better) | 59.5% |
| Revenue growth, 5Y average | 29.8% | 68.8% (better) |
| Profitability | ||
| Gross margin | 84.4% (better) | 57.2% |
| Operating margin | −37.1% | −4.3% (better) |
| Net margin | −39.9% | – |
| FCF margin | −41.3% | −9.6% (better) |
| Return on equity | −72.5% | – |
| Financial health | ||
| Debt / equity | 0.76 | – |
| Interest coverage | −6.9× | −2.5× (better) |
| Current ratio | 2.86 | 3.04 (better) |
| Altman Z-score | 7.42 | – |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 102% | 28.4% |
| Held by insiders | 0.89% | 0.50% |
| Insider net buying, 12 months | −$133M | −$384K (better) |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 6.5% | – |
Go deeper
- INSM stock overview
- INSM income statement
- INSM valuation and score
- LEGN stock overview
- LEGN income statement
- LEGN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.